Results 131 to 140 of about 76,183,421 (152)
Some of the next articles are maybe not open access.
Substance Use Disorder Following Consumption of a Novel Synthetic 7-Hydroxymitragynine Product
Journal of Addiction MedicineBackground: Products containing semi-synthetic 7-hydroxymitragynine (7-OH), a potent mu-opioid receptor (MOR) agonist, have proliferated in the United States. In kratom leaf, trace amounts of 7-OH are formed by spontaneous oxidization of kratom’s primary alkaloid, mitragynine.
Brandon Reif +5 more
openaire +2 more sources
Addiction Biology, 2018
AbstractKratom, derived from the plantMitragyna speciosa,is receiving increased attention as an alternative to traditional opiates and as a replacement therapy for opiate dependence. Mitragynine (MG) and 7‐hydroxymitragynine (7‐HMG) are major psychoactive constituents of kratom. While MG and 7‐HMG share behavioral and analgesic properties with morphine,
Scott E. Hemby +4 more
openaire +2 more sources
AbstractKratom, derived from the plantMitragyna speciosa,is receiving increased attention as an alternative to traditional opiates and as a replacement therapy for opiate dependence. Mitragynine (MG) and 7‐hydroxymitragynine (7‐HMG) are major psychoactive constituents of kratom. While MG and 7‐HMG share behavioral and analgesic properties with morphine,
Scott E. Hemby +4 more
openaire +2 more sources
Planta Medica, 2014
Mitragyna speciosa (kratom) is a popular herb in Southeast Asia, which is traditionally used to treat withdrawal symptoms associated with opiate addiction. Mitragynine, 7-hydroxymitragynine, and mitraphylline are reported to be the central nervous system active alkaloids which bind to the opiate receptors.
Vamshi K, Manda +5 more
openaire +2 more sources
Mitragyna speciosa (kratom) is a popular herb in Southeast Asia, which is traditionally used to treat withdrawal symptoms associated with opiate addiction. Mitragynine, 7-hydroxymitragynine, and mitraphylline are reported to be the central nervous system active alkaloids which bind to the opiate receptors.
Vamshi K, Manda +5 more
openaire +2 more sources
Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series
Journal of Addiction MedicineBackground: Kratom ( Mitragyna speciosa ) is increasingly used in the United States as a dietary supplement for pain, mood regulation, and opioid withdrawal.
Emma Fenske +3 more
openaire +1 more source
European Journal of Drug Metabolism and Pharmacokinetics
Kratom, a Southeast Asian tree, has been researched for its potential as a therapeutic for substance use disorders. The most abundant alkaloid in kratom, mitragynine, is being investigated individually for opioid use disorder. However, the active metabolite of mitragynine,7-hydroxymitragynine (7-HMG) has raised concerns because of its high binding ...
Yi-Hua Chiang +9 more
openaire +2 more sources
Kratom, a Southeast Asian tree, has been researched for its potential as a therapeutic for substance use disorders. The most abundant alkaloid in kratom, mitragynine, is being investigated individually for opioid use disorder. However, the active metabolite of mitragynine,7-hydroxymitragynine (7-HMG) has raised concerns because of its high binding ...
Yi-Hua Chiang +9 more
openaire +2 more sources
Determination of ADME properties of mitragynine, 7-hydroxymitragynine, and mitraphylline
Planta Medica, 2014VK Manda +5 more
openaire +1 more source
7-Hydroxymitragynine: Not Your Garden Variety Kratom
American Journal of Forensic Medicine & PathologyDonna M. Papsun +4 more
openaire +1 more source
Semi-synthetic products based on 7-hydroxymitragynine: a public health emergency
Medical Research ArchivesFranco Posa +4 more
openaire +1 more source

